Reviparin Sodium

瑞肝素钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameReviparin Sodium
Drug Alias NameClivarin 1750ClivarineLowmorinClivarinLU-47311 +[6] 
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionAntithrombin-III activators
TargetsAntithrombin-III
Therapy Area/IndicationsBlood Coagulation Disorders
Global Approved IndicationsBlood Coagulation Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIreland
Original Approved Date1992/01/15
Country/TerritoryIrelandJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesValeantAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesAbbott Laboratories
Inactive CompaniesN/A
Active IndicationsBlood Coagulation Disorders
Inactive IndicationsN/A

Other Information

ATC CodeB01AB08
Related LinksWikipediaDrugBankKEGG